These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39060924)

  • 1. Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.
    Jiao F; Pan Y; Du Z; Deng F; Yang X; Wang H; Shen J; Xiang W; Mu Z; Gao C; Bai J
    BMC Pediatr; 2024 Jul; 24(1):477. PubMed ID: 39060924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of incomplete Kawasaki disease in children].
    Jiao FY; Mu ZL; DU ZD; Yang XD; Shen J; Xiang W; Wang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):238-243. PubMed ID: 36946156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].
    ; ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1198-1210. PubMed ID: 38112136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of children with incomplete Kawasaki disease].
    Peng C; Luo YJ; Xing QL; Xiao MC
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1111-1114. PubMed ID: 27817775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment change and coronary artery abnormality in incomplete Kawasaki disease.
    Nomura Y; Yashiro M; Masuda K; Nakamura Y
    Pediatr Int; 2020 Jul; 62(7):779-784. PubMed ID: 32219919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correct identification of incomplete Kawasaki disease.
    Li T; Feng J; Li N; Liu T
    J Int Med Res; 2021 Mar; 49(3):3000605211001712. PubMed ID: 33784852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M; Castellano-Martínez A; Alonso-Ojembarrena A
    Emergencias; 2019 Abr; 31(2):111-114. PubMed ID: 30963739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete Kawasaki Disease in an Infant: A Case Report and Literature Review.
    Idris I; Awadelkarim AM; Saad E; Dayco J; Beker S
    Cureus; 2022 Feb; 14(2):e22122. PubMed ID: 35308689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior uveitis as an early diagnostic marker in incomplete Kawasaki disease.
    Ko KO; Cheon EJ
    BMC Pediatr; 2024 Oct; 24(1):644. PubMed ID: 39390401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Summary of the best evidence on exercise for the prevention and treatment of diabetic foot].
    Guo QJ; Gu Y; Ouyang J; Yu LL; Zhang YZ; Rao JQ; Luo SS; Xu WY
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jul; 39(7):671-678. PubMed ID: 37805697
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of coronary artery abnormality in incomplete Kawasaki disease.
    Sonobe T; Kiyosawa N; Tsuchiya K; Aso S; Imada Y; Imai Y; Yashiro M; Nakamura Y; Yanagawa H
    Pediatr Int; 2007 Aug; 49(4):421-6. PubMed ID: 17587261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin levels in patients with complete and incomplete Kawasaki disease.
    Cho HJ; Choi YE; Song ES; Cho YK; Ma JS
    Dis Markers; 2013; 35(5):505-11. PubMed ID: 24223462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk of coronary artery aneurysm in Kawasaki disease.
    Mossberg M; Mohammad AJ; Kahn F; Segelmark M; Kahn R
    Rheumatology (Oxford); 2021 Apr; 60(4):1910-1914. PubMed ID: 33150451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of Kawasaki disease: Clinical characteristics and onset of fever and gastrointestinal symptoms.
    Liu HQ; Shi XY; Jia PS; Huo YF; Mu MM; Xie L; Wang HL
    Immun Inflamm Dis; 2023 Jul; 11(7):e929. PubMed ID: 37506133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of anti-neutrophil cytoplasmic antibody in diagnosis of Kawasaki disease].
    Jiang ZG; Liu L; Yang CY; Wu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):45-7. PubMed ID: 22289752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease.
    Wang L; Zeng X; Chen B
    Medicine (Baltimore); 2023 Sep; 102(37):e34939. PubMed ID: 37713854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Summary of the best evidence for the use of mechanical insufflation-exsufflation technique in invasive mechanical ventilation patients].
    Liu Z; Han X; Sang X; Yu C; Mao S; Wen H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):828-833. PubMed ID: 37593861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki Disease Presenting with Fever and Jaundice: Case Report.
    Li XQ; Xue P; Zheng YM; Liu S
    Br J Hosp Med (Lond); 2024 Sep; 85(9):1-12. PubMed ID: 39347672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.